Back to ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

GMABGMAB
Showing 8 of 24 quarters

Position history for ARROWSTREET CAPITAL, LIMITED PARTNERSHIPARROWSTREET CAPITAL, LIMITED PARTNERSHIP's holdings in GENMAB A/S

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds 5M shares of GMAB (GENMAB A/S), worth $133.5M as of 2026-Q1. The position was decreased (-0.1% shares). GMAB represents 0.1% of ARROWSTREET CAPITAL, LIMITED PARTNERSHIP's portfolio.

Current Value

$133.5M

Current Shares

5M

Total Value Change

+$132.5M

Total Shares Change

+4.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
5M
-0.1%
$133.5M0.1%$27.66
0
2025-Q4
Increased
5M
+36.6%
$153.3M0.1%$31.49
40
2025-Q3
Increased
3.6M
+5.5%
$111.7M0.1%$29.33
32
2025-Q2
Increased
3.5M
+152.3%
$71.4M0.1%$20.50
48
2025-Q1
Increased
1.4M
+4398.7%
$26.8M0.0%$19.90
46
2024-Q4
Decreased
30,440
-67.5%
$635,2830.0%$20.77
0
2024-Q3
Increased
93,628
+150.3%
$340,9890.0%$24.33
38
2024-Q2
New
37,409
-
$940,0000.0%$25.13
35

Other major holders of GMAB: ALLIANCEBERNSTEIN L.P., Orbis Allan Gray Ltd

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used